Nippon Mutual Fund

Nippon India Pharma Fund (G)

₹ 471.04

NAV (Apr 11)

22.396%
5 Year CAGR
Scripbox Opinion
neutral-badge
Neutral
Click here for top ranked funds in sectoral / thematic - pharma and healthcare mutual funds.

Sectoral / Thematic - Pharma And Healthcare funds provides inflation beating growth over the long term and is suitable for investment objectives with duration of 10-15 years or longer (minimum 5 years).

The pharma benchmark index itself has been a material underperformer over an extended time frame.

Contrary to common perception, this category is also characterised by higher volatility.Investing in these funds will require investors to have a unique insight into the specific areas of investment that these funds focus on.In addition the investor will need to have the ability,inclination and expertise to monitor the prospects closely.Investors are therefore better off investing in diversified funds rather than this category.

Our analysis of this fundLearn how we rate funds ->

Downside Protection Measure

Neutral

The performance of the fund on a Downside Protection Measure metric has been Neutral

Fund Size

Category Leader

The fund has been a Category Leader on the Fund Size metric

View all 4 analysis

cheveron-blue

View Less

cheveron-blue

Nippon India Pharma Fund (G) Calculator

Investment Duration5 years

7,32,612

Total Investment

5,66,635

Wealth Gained

12,99,247

Total Corpus Created (₹)

With CAGR of 22.396 % in 5 years

Historical NAV

₹ 471.0386

NAV (Apr 11)

Fund Returns

Last 1Y
9.2%
Last 3Y
16.6%
Last 5Y
22.4%
Last 10Y
12.6%
Since Inception
20.3%
6 Month CAGR
-10.6%

Scheme Information

Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Expense Ratio
1.82 %
Launched 20Y ago
2004-06-05
AUM in Crores
8081
ISIN
INF204K01968
Lock-in (days)
No Lock-in
Benchmark
BSE Healthcare Total Return Index
SIP Minimum
1000
Lumpsum Min.
5000
Standard Deviation
15.6
Beta
0.9
Sharpe Ratio
0.7
star-circle

Returns Calculator Comparison

of

for

with step up of

AssetReturnsTotal CorpusGainsCAGR
Nippon India Pharma Fund (G)70%12,99,247 5,66,63522.4%
EPF70% 9,00,761 1,68,1498.50%
Property70% 8,67,662 1,35,0507.00%
PPF70% 8,69,819 1,37,2077.10%
Bank FD70% 8,46,471 1,13,8596.00%
Gold70% 8,46,471 1,13,8596.00%
Savings Bank70% 8,25,950 93,3385.00%

Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.

asset-allocation

Asset allocation and Holdings

Last updated on 2025-03-12

Top Stock Holdings

Sun Pharmaceutical Industries Ltd.

13.85%
13.85%

Divi's Laboratories Ltd.

8.17%
8.17%

Lupin Ltd.

7.52%
7.52%

Cipla Ltd.

5.88%
5.88%

Dr. Reddy's Laboratories Ltd.

5.81%
5.81%
See all holdings
right-arrow

Allocation by Sector

Healthcare

98.88%
98.88%
See all sectors
right-arrow
comparison

Comparison with Equity Funds

amc-img

About the AMC

Nippon India Mutual Fund

Reliance Nippon India Mutual Fund was established in 1996. It is a joint venture between India's Reliance Mutual Fund and Japan's Nippon Life Insurance Company. It is india's top asset management company with a total AUM of Rs 1.8 Lac Crore with about 91.9 lac active folios. It is the first compnay to be listed and traded on both the NSE and Bombay Stock Exchange (BSE).amc-img
Fund NameScripbox Opinion
Till Date CAGR

6.5%

6.9%

8.9%

8.9%

18.3%

20.3%

16%

12.5%

6.2%

5.1%

Nippon India Pharma Fund (G) Calculator

Investment Duration5 years

7,32,612

Total Investment

5,66,635

Wealth Gained

12,99,247

Total Corpus Created (₹)

With CAGR of 22.396 % in 5 years

Nippon India Pharma Fund (G) Review

Nippon India Pharma Fund (G) is a Sectoral / Thematic - Pharma And Healthcare Equity fund and has delivered an annualised return of 20.28% over 20 years. The fund has grown over a period of 20 years. The fund is managed by Nippon India Mutual Fund. The fund manager’s name is Sailesh Raj Bhan.

Nav of Nippon India Pharma Fund (G) as of 4/11/2025 is ₹471.04 with the total AUM as of 4/13/2025 is ₹8080.97. With Scripbox you can compare and check the latest nav for all mutual funds in India. Nippon India Pharma Fund (G) was launched on 2004-06-05. The category risk of the fund is Very High.

The minimum SIP amount for Nippon India Pharma Fund (G) is ₹1000 and you can increase this in multiples of ₹100. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000. Check your estimated returns on mutual funds by using sip calculator.

Nippon India Pharma Fund (G) is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to BSE Healthcare Total Return Index.

Scripbox provides a compare mutual funds research tool to view a detailed comparison with Nippon India Pharma Fund (G).

Frequently Asked Questions

What is Nippon India Pharma Fund (G)?

How to invest in Nippon India Pharma Fund (G)?

What is the minimum sip amount of Nippon India Pharma Fund (G)?

Is Nippon India Pharma Fund (G) good to invest in?

What is the expense ratio of the Nippon India Pharma Fund (G)?

What is the NAV of Nippon India Pharma Fund (G)?

Nippon India Pharma Fund (G) Calculator

Investment Duration5 years

7,32,612

Total Investment

5,66,635

Wealth Gained

12,99,247

Total Corpus Created (₹)

With CAGR of 22.396 % in 5 years